Los Angeles, CA – May 29, 2018 — Worldwide Business with kathy ireland® is pleased to announce an exclusive interview with Analytical Lab Group CEO Alan Roth to discuss comprehensive testing solutions for infection prevention, contamination control and product integrity.

Analytical Lab Group is a leader in working with clients in the antimicrobial, pharmaceutical and medical device market segments to safeguard public health. They partner with developers and manufacturers to support product development in the life science industry. Additionally, they work with end users of infection prevention and contamination control products to qualify and validate in-use procedures. The company provides FDA compliance expertise and testing solutions, as well as testing solutions to validate product label claims for EPA approval.

“We provide comprehensive testing solutions for products designed to assist with infection prevention and contamination control,” Roth said, and these “solutions are being used in healthcare facilities daily to combat infections, ultimately helping reduce the loss of lives.

“Recent numbers indicated that 700,000 people in the U.S. alone are having infections while staying in hospitals, with 70,000 of those individuals dying. We are the industry experts in contamination control and infection prevention.”

Analytical Lab Group validates the legitimacy of product performance claims made by manufacturers, supplying data to their clients that accompanies their product registration filings required before product can be approved for sale. ALG is also expanding its cell banking services. Its GMP facilities provide cell bank preparation services for mammalian and bacterial cell banks used in the development of pharmaceutical and therapeutic products. Analytical Lab Group also performs quality control product release testing and environmental monitoring to help safeguard public health.

One of their recent accomplishments is partnering with Light Line Medical on efficacy testing. Light Line Medical is introducing a revolutionary product into the market. Their solution uses the antimicrobial properties of physical light incorporated into catheters to decontaminate the outside and inside of these medical devices, which are the leading route of infections in hospitals and nursing homes.

“The work they are doing is phenomenal,” says J.L. Haber, Vice President of Programming. “Anything that helps keep infections and disease at bay from harming the general public is a step in the right direction.”

For more information on Analytical Lab Group’s antimicrobial, pharmaceutical, medical device and biotechnology services, contact Analytical Lab Group or visit analyticallabgroup.com and tune in to this sponsored content on Fox Business Network on Sunday, June 3, 2018, at 5 p.m. EST and Bloomberg International at 7 a.m. GMT, 10 a.m. D.F. and 2:30 p.m. HKT.

About Worldwide Business with kathy ireland®